Research Frontiers Reports Third Quarter 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today
WOODBURY, N.Y., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: ) announced its financial results for its third quarter of 2024. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.
| • | Who: Joseph M. Harary, President & CEO | |
| • | Date/Time: Thursday, November 7, 2024, 4:30 PM ET | |
| • | Dial-in Information:1-888-334-5785 | |
| • | Replay: Available on Friday, November 8, 2024 for 90 days at | |
Key Comments:
| 1. | Revenue Growth, Especially in the Automotive and Aircraft Markets Research Frontiers royalty income increased by over 115% in the third quarter compared to last year, marking the seventh consecutive quarter of revenue growth from the same period in the prior year. The automotive and aircraft markets demonstrated particularly robust growth, each posting triple-digit percentage gains, fueling this upward trend. Research Frontiers’ revenue for the first nine months of 2024 surpassed total revenue for all of calendar year 2023, supported by strong growth across automotive, aircraft, and architectural markets. Total royalty income for the first nine months of 2024 rose by over 93% compared to the same period last year. |
| 2. | Expansion of Product Pipeline. The Company expects revenue in all market segments to increase as new car models, aircraft, trains, architectural, information display and other products using the Company’s SPD-SmartGlass technology are introduced into the market. The Company anticipates multiple new car models featuring SPD-SmartGlass technology in 2025 from OEMs in Asia and Europe. |
| 3. | Operational Efficiencies and Financial Stability. Expenses decreased by approximately $92,000 for the third quarter and by over $150,000 for the nine month period ending September 30, 2024. These efficiencies, combined with rising revenue, reduced the Company’s quarterly net loss to $0.00 per share in the third quarter and $0.02 per share for the nine months ending September 30, 2024. At September 30, 2024, the Company had cash and cash equivalents of approximately $1.65 million, and working capital of $2.7 million. The Company has no debt and expects to have sufficient working capital for at least the next five years of operations. |
For more details, please see the Company’s Quarterly Report on Form 10-Q which was filed today with the SEC, the contents of which are incorporated by reference herein.
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to numerous companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at , and on , , and .
Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.
CONTACT:
Joseph M. Harary
President and CEO
Research Frontiers Inc.
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Balance Sheets
| September 30, 2024 (Unaudited) | December 31, 2023 (See Note 1) | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 1,647,987 | $ | 2,475,958 | ||||
| Royalties receivable, net of reserves of $1,253,450 in 2024 and 2023, respectively | 1,048,008 | 1,003,404 | ||||||
| Prepaid expenses and other current assets | 154,727 | 96,784 | ||||||
| Total current assets | 2,850,722 | 3,576,146 | ||||||
| Fixed assets, net | 20,758 | 39,598 | ||||||
| Operating lease ROU assets | 71,486 | 178,715 | ||||||
| Deposits and other assets | 56,066 | 56,066 | ||||||
| Total assets | $ | 2,999,032 | $ | 3,850,525 | ||||
| Liabilities and Shareholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Current portion of operating lease liability | $ | 109,968 | $ | 212,359 | ||||
| Accounts payable | 34,306 | 50,880 | ||||||
| Accrued expenses | 31,799 | 14,192 | ||||||
| Total current liabilities | 176,073 | 277,431 | ||||||
| Operating lease liability, net of current portion | - | 55,363 | ||||||
| Total liabilities | 176,073 | 332,794 | ||||||
| Shareholders’ equity: | ||||||||
| Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 33,517,787 in 2024 and 33,509,287 in 2023 | 3,352 | 3,351 | ||||||
| Additional paid-in capital | 127,787,890 | 127,779,221 | ||||||
| Accumulated deficit | (124,968,283 | ) | (124,264,841 | ) | ||||
| Total shareholders’ equity | 2,822,959 | 3,517,731 | ||||||
| Total liabilities and shareholders’ equity | $ | 2,999,032 | $ | 3,850,525 | ||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Operations
(Unaudited)
| Nine months ended September 30, | Three months ended September 30, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Fee income | $ | 1,157,380 | $ | 597,362 | $ | 354,408 | $ | 164,146 | ||||||||
| Operating expenses | 1,565,152 | 1,695,129 | 454,866 | 542,635 | ||||||||||||
| Research and development | 409,817 | 430,150 | 131,246 | 135,319 | ||||||||||||
| Total expenses | 1,974,969 | 2,125,279 | 586,112 | 677,954 | ||||||||||||
| Operating loss | (817,589 | ) | (1,527,917 | ) | (231,704 | ) | (513,808 | ) | ||||||||
| Net investment income | 78,995 | 99,463 | 29,736 | 41,642 | ||||||||||||
| Other income | 35,152 | - | 35,152 | - | ||||||||||||
| Net loss | $ | (703,442 | ) | $ | (1,428,454 | ) | $ | (166,816 | ) | $ | (472,166 | ) | ||||
| Basic and diluted net loss per common share | $ | (0.02 | ) | $ | (0.04 | ) | $ | (0.00 | ) | $ | (0.01 | ) | ||||
| Weighted average number of common shares outstanding | 33,515,327 | 33,435,074 | 33,517,787 | 33,509,287 | ||||||||||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Shareholders’ Equity
(Unaudited)
For the nine months ended September 30, 2023 and 2024
| Common Stock | Additional Paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
| Balance, January 1, 2023 | 33,150,396 | $ | 3,315 | $ | 127,150,027 | $ | (122,356,477 | ) | $ | 4,796,865 | ||||||||||
| Exercise of warrants | 358,891 | 36 | 484,466 | - | 484,502 | |||||||||||||||
| Net loss | - | - | - | (1,428,454 | ) | (1,428,454 | ) | |||||||||||||
| Balance, September 30, 2023 | 33,509,287 | $ | 3,351 | $ | 127,634,493 | $ | (123,784,931 | ) | $ | 3,852,913 | ||||||||||
| Common Stock | Additional Paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
| Balance, January 1, 2024 | 33,509,287 | $ | 3,351 | $ | 127,779,221 | $ | (124,264,841 | ) | $ | 3,517,731 | ||||||||||
| Exercise of options | 8,500 | 1 | 8,669 | - | 8,670 | |||||||||||||||
| Net loss | - | - | - | (703,442 | ) | (703,442 | ) | |||||||||||||
| Balance, September 30, 2024 | 33,517,787 | $ | 3,352 | $ | 127,787,890 | $ | (124,968,283 | ) | $ | 2,822,959 | ||||||||||
For the three months ended September 30, 2023 and 2024
| Common Stock | Additional Paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
| Balance, June 30, 2023 | 33,509,287 | $ | 3,351 | $ | 127,634,493 | $ | (123,312,765 | ) | $ | 4,325,079 | ||||||||||
| Net loss | - | - | - | (472,166 | ) | (472,166 | ) | |||||||||||||
| Balance, September 30, 2023 | 33,509,287 | $ | 3,351 | $ | 127,634,493 | $ | (123,784,931 | ) | $ | 3,852,913 | ||||||||||
| Common Stock | Additional Paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
| Balance, June 30, 2024 | 33,517,787 | $ | 3,352 | $ | 127,787,890 | $ | (124,801,467 | ) | $ | 2,989,775 | ||||||||||
| Net loss | - | - | - | (166,816 | ) | (166,816 | ) | |||||||||||||
| Balance, September 30, 2024 | 33,517,787 | $ | 3,352 | $ | 127,787,890 | $ | (124,968,283 | ) | $ | 2,822,959 | ||||||||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| For the nine months ended September 30, | ||||||||
| 2024 | 2023 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (703,442 | ) | $ | (1,428,454 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 19,582 | 20,489 | ||||||
| Realized gain on marketable securities | - | (26,375 | ) | |||||
| Unrealized gain on marketable securities | - | (30,399 | ) | |||||
| ROU asset amortization | 107,229 | 109,051 | ||||||
| Credit loss expense | 25,001 | 95,000 | ||||||
| Change in assets and liabilities: | ||||||||
| Royalty receivables | (69,605 | ) | (226,645 | ) | ||||
| Prepaid expenses and other assets | (57,943 | ) | (63,612 | ) | ||||
| Accounts payable and accrued expenses | 1,033 | (52,784 | ) | |||||
| Deferred revenue | - | 3,735 | ||||||
| Operating lease liability | (157,754 | ) | (146,323 | ) | ||||
| Net cash used in operating activities | (835,899 | ) | (1,746,317 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of fixed assets | (742 | ) | (1,265 | ) | ||||
| Purchases of marketable securities | - | (5,434,386 | ) | |||||
| Sales of marketable securities | - | 2,991,535 | ||||||
| Net cash used in investing activities | (742 | ) | (2,444,116 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Net proceeds from exercise of options and warrants | 8,670 | 484,502 | ||||||
| Net cash provided by financing activities | 8,670 | 484,502 | ||||||
| Net decrease in cash and cash equivalents | (827,971 | ) | (3,705,931 | ) | ||||
| Cash and cash equivalents at beginning of period | 2,475,958 | 4,230,916 | ||||||
| Cash and cash equivalents at end of period | $ | 1,647,987 | $ | 524,985 | ||||
